Vickers Ballas Capital

Vickers Ballas Capital was the investment banking and corporate finance arm of Vickers Ballas Holdings, a prominent Singapore-based financial services group. The firm was a significant participant in Southeast Asian capital markets, offering services in securities brokerage, fund management, and corporate advisory throughout the 1990s. In 2001, the company merged with DBS Securities to form DBS Vickers Securities, becoming a subsidiary of DBS Bank. While not a biotechnology company itself, Vickers Ballas is highly relevant to the life sciences sector as the predecessor entity for the founders of Vickers Venture Partners. Vickers Venture Partners has since become a major global investor in biotechnology, supporting high-profile companies in fields such as regenerative medicine, oncology, and drug delivery platforms. Consequently, the Vickers Ballas name is frequently associated with the early financing and institutional support of the Asian biotech ecosystem.